Therefore, the endothelial markers, CD31 and FVIII, in addition to immunopositivity for vascular markers, CD34 and FVIII related antigen, may be added to the immunohistochemical panel when determining a diagnosis of angiosarcoma (11,12). This evidence concerns the gene CD34 and angiosarcoma.